Respiratory Oxygen Delivery Devices Market Report 2025

This Respiratory Oxygen Delivery Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The respiratory oxygen delivery devices market size has grown rapidly in recent years. It will grow from $15 billion in 2024 to $16.66 billion in 2025 at a compound annual growth rate (CAGR) of 11%. The growth in the historic period can be attributed to the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis, the growing aging population worldwide, rising awareness about the importance of respiratory health, expansion of healthcare expenditure in emerging economies, and increasing adoption of homecare settings for respiratory therapy.

The respiratory oxygen delivery devices market size is expected to see rapid growth in the next few years. It will grow to $25.01 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to the growing demand for personalized and precision medicine in respiratory care, expansion of home healthcare services and remote patient monitoring, rising investments in research and development, and increasing focus on preventive healthcare and early intervention strategies. Major trends in the forecast period include technological innovations, shift towards value-based care models and patient-centric approaches, integration of telehealth and remote monitoring capabilities into respiratory therapy platforms, utilization of wearables and mobile applications for self-management of respiratory conditions, and adoption of 3D printing and digital manufacturing techniques.

The growing incidence of asthma is anticipated to fuel the expansion of the respiratory oxygen delivery device market in the coming years. Asthma, a chronic respiratory disorder, is marked by airway inflammation and constriction, resulting in repeated bouts of wheezing, coughing, chest tightness, and breathlessness. Factors contributing to the rising asthma cases include air pollution, exposure to allergens, genetic susceptibility, lifestyle and dietary shifts, and urbanization. Respiratory oxygen delivery devices play a crucial role in managing asthma by delivering supplemental oxygen therapy during exacerbations, helping to maintain proper oxygen levels and reduce symptoms, thereby improving respiratory function and quality of life for asthma patients. For example, in May 2024, data from the National Center for Health Statistics (NCHS), a U.S.-based health statistics agency, reported that the prevalence of current asthma among adults aged 18 and over in the U.S. rose from 8.4% in 2021 to 8.7% in 2022. Additionally, asthma episodes within the past 12 months for adults in the same age group increased from 3.3% in 2021 to 3.7% in 2022. Consequently, the rising prevalence of asthma is bolstering the respiratory oxygen delivery device market.

Enterprises in the respiratory oxygen delivery device market are concentrating on integrating advanced sensor control systems and interconnected connectivity features into oxygen concentrator devices, such as pressure swing adsorption (PSA) technology, to enhance patient monitoring, optimize treatment outcomes, and streamline healthcare delivery processes. PSA technology in oxygen concentrators effectively separates oxygen from nitrogen in ambient air, ensuring a consistent and dependable oxygen supply for patients requiring respiratory support. For instance, in July 2022, OMRON Healthcare Co. Ltd., a Japanese medical device manufacturing company, introduced a medical molecular sieve oxygen concentrator, a portable device designed to deliver a continuous supply of high-purity oxygen. By employing pressure swing adsorption (PSA) technology to extract nitrogen, oxygen, and other elements from ambient air, the concentrator ensures efficiency and quality while maintaining portability. Aimed at meeting the therapy and lifestyle requirements of patients with chronic obstructive pulmonary disease (COPD) and respiratory issues, the device offers a convenient solution for home care providers and highly active users, prioritizing mobility and durability with features such as a 360-degree mute wear-resistant universal caster wheel and a high-impact-resistant design.

In February 2023, React Health Inc., a US-based manufacturer and distributor of medical devices for sleep-disordered breathing and oxygen therapy, completed the acquisition of a respiratory product line from Invacare Holdings Corporation for an undisclosed sum. This acquisition broadens React Health's product portfolio to encompass essential respiratory devices, strengthening its foothold in the medical device market, particularly in sleep-disordered breathing and oxygen therapy treatments. Invacare Holdings Corporation is a US-based manufacturing company specializing in respiratory therapy medical equipment, including stationary oxygen concentrators and oxygen refilling devices.

Major companies operating in the respiratory oxygen delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson and Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group, Teleflex Incorporated, Masimo Corporation, Chart Industries Inc., Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hamilton Medical AG, GaleMed Corporation, Weinmann Emergency Medical Technology GmbH + Co. KG, Precision Medical Inc., Allied Healthcare Products Inc., Salter Labs Inc., Nidek Medical Products Inc.

Asia-Pacific was the largest region in the respiratory oxygen delivery devices market in 2024. The regions covered in the respiratory oxygen delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the respiratory oxygen delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Respiratory oxygen delivery devices are medical tools crafted to administer oxygen to patients requiring supplemental oxygen therapy to support their breathing. They are employed to provide oxygen therapy to individuals with respiratory conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, other lung diseases, as well as those experiencing hypoxemia due to various medical conditions or environmental factors.

The primary product types of respiratory oxygen delivery devices include oxygen masks, nasal cannulas, ventilator masks, non-rebreather masks, bag valve masks, continuous positive airway pressure (CPAP) masks, among others. Oxygen masks are designed to deliver oxygen to patients by covering the nose and mouth, facilitating the inhalation of oxygen-enriched air. These devices are utilized across applications such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, respiratory distress syndrome, pneumonia, among others, and are utilized by end-users including hospitals, outpatient facilities, and home care settings.

The respiratory oxygen delivery devices market research report is one of a series of new reports that provides respiratory oxygen delivery devices market statistics, including respiratory oxygen delivery devices industry global market size, regional shares, competitors with a respiratory oxygen delivery devices market share, detailed respiratory oxygen delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory oxygen delivery devices industry. This respiratory oxygen delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The respiratory oxygen delivery devices market consists of sales of nasal cannulas, oxygen masks, oxygen concentrators, and oxygen cylinders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.